Public articles linked to the same research event.
Nature News A single-nucleus RNA-sequencing atlas of the human dorsolateral prefrontal cortex built from nearly 1,500 donors and more than 6.3 million nuclei, together with the companion statistical tool Dreamlet, characterizes cell-type-specific transcriptional changes across eight brain disorders, reports shared cross-disease signatures, cell-composition shifts along Alzheimer's disease progression, and marked up-regulation of PTPRG in microglia.
A single-nucleus RNA-sequencing atlas of the human dorsolateral prefrontal cortex built from nearly 1,500 donors and more than 6.3 million nuclei, together with the companion statistical tool Dreamlet, characterizes cell-type-specific transcriptional changes across eight brain disorders, reports shared cross-disease signatures, cell-composition shifts along Alzheimer's disease progression, and marked up-regulation of PTPRG in microglia.
A single-nucleus RNA-sequencing atlas of the human dorsolateral prefrontal cortex built from nearly 1,500 donors and more than 6.3 million nuclei, together with the companion statistical tool Dreamlet, characterizes cell-type-specific transcriptional changes across eight brain disorders, reports shared cross-disease signatures, cell-composition shifts along Alzheimer's disease progression, and marked up-regulation of PTPRG in microglia.
A single-nucleus RNA-sequencing atlas of the human dorsolateral prefrontal cortex built from nearly 1,500 donors and more than 6.3 million nuclei, together with the companion statistical tool Dreamlet, characterizes cell-type-specific transcriptional changes across eight brain disorders, reports shared cross-disease signatures, cell-composition shifts along Alzheimer's disease progression, and marked up-regulation of PTPRG in microglia.